|

Long-term course of antiandrogen drugs Clinical Trials

1 actively recruiting trial

Also known as: Rezvilutamide

Pipeline

Phase 3: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)1
  • Cancer1

Other1 trial

Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.